July 22 nd 2019 Peter Hoang President & Chief Executive Officer 1 2 3 Brandon G. Smaglo M.D., FACP Lead investigator and Assistant Professor of Oncology at Baylor College of Medicine 4 5 6 7 8 9 10 11 12 13 14 15 16 17 1
Monday, July 22, 2019 BiopharmaWatch Research 1 min read
Key Takeaway: Peter Hoang President & Chief Executive Officer
Brandon G. Smaglo M.D., FACP Lead investigator and Assistant Professor of Oncology at Baylor College of Medicine
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+35%
120-day peak, hindsight
Typical move
5.1%
average across 5 past catalysts
Cash runway
~9 mo
Medium dilution risk
Lead asset
Low dose FRα vaccine
Phase 2 · Breast Cancer
Full Press Release Details
Peter Hoang President & Chief Executive Officer
Brandon G. Smaglo M.D., FACP Lead investigator and Assistant Professor of Oncology at Baylor College of Medicine